
- /
- Supported exchanges
- / US
- / EXAS.NASDAQ
EXACT Sciences Corporation (EXAS NASDAQ) stock market data APIs
EXACT Sciences Corporation Financial Data Overview
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with EXACT Sciences Corporation (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get EXACT Sciences Corporation data using free add-ons & libraries
Get EXACT Sciences Corporation Fundamental Data
EXACT Sciences Corporation Fundamental data includes:
- Net Revenue: 2 940 M
- EBITDA: 78 282 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: -0.13
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EXACT Sciences Corporation News

Stock Of The Day: Why IBD 50's Guardant Health Has Rallied 231% In A Month
Guardant Health stock broke out of a cup base as enthusiasm builds for the company's new blood test, Shield MCD. Continue Reading View Comments


Should You Take a Closer Look at Exact Sciences After Its Recent 17% Surge?
If you're reading this, you've probably found yourself staring at Exact Sciences stock on your watchlist, asking the million-dollar question: is now the time to act? After a rollercoaster year, the co...

How Recent Partnerships and Launches Are Shaping Exact Sciences’s Valuation and Growth Outlook
Exact Sciences stock has seen its consensus analyst price target rise from $65.38 to $69.16, signaling renewed optimism in the company's growth prospects. This upward adjustment reflects enhanced conf...

Grail Blood Test Found Seven Times More Cancers Than Standard Tests, Data Show
Grail shared the results of it Pathfinder 2 study during a meeting of the European Society for Medical Oncology in Berlin on Saturday. Continue Reading View Comments
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.